Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) FCF Margin (2022 - 2025)

Historic FCF Margin for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 171.27%.

  • bioAffinity Technologies' FCF Margin fell 981500.0% to 171.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 125.53%, marking a year-over-year decrease of 479300.0%. This contributed to the annual value of 78.44% for FY2024, which is 1608700.0% up from last year.
  • Latest data reveals that bioAffinity Technologies reported FCF Margin of 171.27% as of Q3 2025, which was down 981500.0% from 209.58% recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' FCF Margin ranged from a high of 65.09% in Q2 2024 and a low of 169528.23% during Q1 2023
  • In the last 4 years, bioAffinity Technologies' FCF Margin had a median value of 190.43% in 2025 and averaged 29650.22%.
  • As far as peak fluctuations go, bioAffinity Technologies' FCF Margin soared by 1694290200bps in 2024, and later crashed by -1444900bps in 2025.
  • Over the past 4 years, bioAffinity Technologies' FCF Margin (Quarter) stood at 55440.58% in 2022, then surged by 100bps to 72.42% in 2023, then fell by -5bps to 75.97% in 2024, then tumbled by -125bps to 171.27% in 2025.
  • Its FCF Margin stands at 171.27% for Q3 2025, versus 209.58% for Q2 2025 and 91.31% for Q1 2025.